Table 2. Univariate and multivariate analyses of the correlations of KLRB1 expression with OS in breast cancer patients.
Parameters | HR | CI 95% | P value | HR | CI 95% | P value |
---|---|---|---|---|---|---|
Age | 1.91 | 1.39–2.63 | 0.000 | 2.12 | 1.32–3.39 | 0.0020 |
Histological type | 0.93 | 0.74–1.17 | 0.543 | |||
Molecular subtype | 1.01 | 0.88–1.16 | 0.901 | |||
ER | 0.85 | 0.71–1.02 | 0.074 | |||
PR | 0.87 | 0.73–1.03 | 0.096 | |||
HER2 | 1.29 | 1.05–1.57 | 0.013 | 1.22 | 0.98–1.52 | 0.0720 |
Menopause status | 1.16 | 0.94–1.43 | 0.165 | |||
Stage | 1.64 | 1.4–1.91 | 0.000 | 1.97 | 1.52–2.55 | 0 |
Lymph node status | 1.10 | 0.93–1.3 | 0.274 | |||
Margin status | 1.42 | 1.11–1.81 | 0.005 | 1.05 | 0.76–1.47 | 0.7570 |
KLRB1 | 1.88 | 1.37–2.59 | 0.000 | 2.37 | 1.49–3.76 | 0 |
Notes.
Abbreviations
- HR
- Hazard Ratio
- CI
- confidence interval
Bold values of P < 0.05 indicate statistically significant correlations.